FDA
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/17: (CVAC) (TCON) (GOLD) Higher; (SRNE) Lower (more...)
-
-
-
-
-
-
-
Principia Updates PRN1008 Pemphigus Clinical Program
-
-
-
-
-
-
-
Principia Biopharma Inc. (PRNB) Granted PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura
-
322,137 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

